Zhongqing Zou
Zhongqing Zou
1
Department of Hematology, Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China
1,†,
Sihan Lai
Sihan Lai
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,†,
Hai Yi
Hai Yi
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,
Qian Zhang
Qian Zhang
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,
Hao Yao
Hao Yao
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,
Hui Yang
Hui Yang
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,
Ling Zhang
Ling Zhang
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,
Alex H Chang
Alex H Chang
3
Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
4
Shanghai YaKe Biotechnology Ltd., Shanghai, China
3,4,*,
Yi Su
Yi Su
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
2,*,
Jin Rao
Jin Rao
1
Department of Hematology, Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China
1,*
1
Department of Hematology, Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China
2
Department of Hematology, The General Hospital of Western Theater Command, Sichuan Clinical Research Center for Hematological Disease, Branch of National Clinical Research Center for Hematological Disease, Chengdu, China
3
Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
4
Shanghai YaKe Biotechnology Ltd., Shanghai, China
Edited and reviewed by: Avichai Shimoni, Sheba Medical Center, Israel
✉*Correspondence: Alex H. Chang, changah@yakebiotech.com; Yi Su, suhang1234@hotmail.com; Jin Rao, raojin720325@163.com
†These authors have contributed equally to this work
Received 2025 Jul 28; Accepted 2025 Aug 14; Collection date 2025.
Keywords: primary central nervous system lymphoma (PCNSL), T-cell lymphoma, cerebellar, ALK, ALCL, CAR-T, CD30, CD7
Copyright © 2025 Zou, Lai, Yi, Zhang, Yao, Yang, Zhang, Chang, Su and Rao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
